Themis Medicare Ltd.

208.50 -0.60 ▼-0.3%

16 April 2024, 04:12:14 PM
Volume: 50,697

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.themismedicare.com
Market Cap 1,919.04 Cr.
Enterprise Value(EV) 1,991.24 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.92 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 42.38 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 39.78 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.24 Calculated using Price: 208.50
Dividend Yield 0.24 Period Ending 2023-03
No. of Shares Subscribed 9.20 Cr. 92,040,120 Shares
FaceValue 1
About Themis Medicare Ltd.
Themis Medicare (TML) incorporated in 1969, is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. Erstwhile known as Themis Chemical the company is promoted by Mr. Shantibhai D. Patel. It is joint venture with Gedeon Richter, Hungary.

Themis Medicare Ltd. Delivery

Delivered Qty
Traded Qty

Themis Medicare Ltd. Performance

1 Day
-0.29%
1 Week
-8.49%
1 Month
-2.43%
3 Month
-3.00%
6 Month
+23.05%
1 Year
+56.37%
2 Year
+128.82%
5 Year
+609.18%
10 Year
+3230.67%

Themis Medicare Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.4 22.85 13.16 5.42 -8 9.34 13.09 28.84 18.16
Return on Capital Employed (%) 9.45 14.69 12.92 8.52 -1.25 11.81 15.21 31.07 20.59
Return on Assets (%) 1.94 5.52 5.29 2.95 -4.29 4.86 7.32 17.93 11.78

Themis Medicare Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 59 74 152 169 158 183 219 287 339 364
Non Curr. Liab. 82 71 8 7 3 8 24 31 35 35
Curr. Liab. 136 130 124 125 147 155 128 124 149 149
Minority Int. 0 0
Equity & Liab. 277 275 284 301 307 345 371 442 524 548
Non Curr. Assets 143 142 160 157 158 165 186 214 249 263
Curr. Assets 133 133 124 143 150 180 185 228 275 285
Misc. Exp. not W/O
Total Assets 277 275 284 301 307 345 371 442 524 548

Themis Medicare Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 202 232 217 210 184 202 231 395 354 364
Other Income 13 3 3 3 3 3 4 7 12 7
Total Income 214 236 220 213 186 205 234 401 366 371
Total Expenditure -184 -194 -184 -185 -181 -166 -181 -299 -287 -311
PBIDT 31 41 36 28 5 39 53 102 79 59
Interest -15 -12 -12 -12 -12 -13 -13 -9 -10 -10
Depreciation -11 -12 -7 -7 -8 -8 -9 -9 -10 -12
Taxation 1 -2 -2 0 2 -2 -6 -22 -16 -10
Exceptional Items
PAT 5 15 15 9 -13 16 26 73 57 28
Minority Interest 0 0
Share Associate 1 1 1 3 2 9 9 18
Other Related Items
Consolidated Net Profit 6 16 16 11 -11 25 36 73 57 45
Adjusted EPS 1 2 2 1 -1 3 4 8 6 5

Themis Medicare Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 8 19 26 -2 8 11 0 57 34 16
Cash Fr. Inv. -7 -6 -7 -4 0 -4 -5 -16 -16 -24
Cash Fr. Finan. 2 -18 -13 5 -9 -10 7 -26 -18 0
Net Change 4 -5 5 0 -1 -3 2 16 1 -8
Cash & Cash Eqvt -35 -40 -34 6 4 2 3 19 20 13

Themis Medicare Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 67.18 67.18 67.18 67.18 67.18 67.16 67.16 67.16 67.16
Public 32.82 32.82 32.82 32.82 32.82 32.84 32.84 32.84 32.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 23.51 23.51 23.51 23.51 23.51 23.51 23.51 23.51 2.43
No. of Shareholders (in Lacs)

Themis Medicare Ltd. Announcements

Mon, 08 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Themis Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mon, 08 Apr 2024
Shareholders meeting
Themis Medicare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Wed, 27 Mar 2024
Trading Window-XBRL
THEMIS MEDICARE LIMITED has informed the Exchange about Closure of Trading Window

Themis Medicare Ltd. Technical Scans

Tue, 16 Apr 2024
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
CCI Oversold Zone CCI Oversold Zone

Themis Medicare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 368,765.79 1,536.95 -0.3%
Cipla Ltd. 111,101.58 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. 100,958.41 6,038.00 +0.5%
Divi's Laboratories Ltd. 99,939.63 3,755.15 +1.1%
Zydus Lifesciences Ltd. 95,104.21 937.80 +0.3%
Mankind Pharma Ltd. 91,420.29 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. 91,073.20 6,327.80 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.41 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-12 29.96 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.31 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 72.26 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.98 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-12 52.93 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.38 6,327.80 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.91 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-12 4.29 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.76 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.67 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.05 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.29 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.48 6,327.80 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,327.80 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,327.80 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,327.80 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,327.80 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,327.80 +0.4%

Themis Medicare Ltd. FAQ's

What is Themis Medicare share price?

Can I buy Themis Medicare shares now?

What is the Dividend Yield of Themis Medicare?

What is the Market Cap of Themis Medicare?

What are the key metrics to analyse Themis Medicare?

What is the 52 Week High and Low of Themis Medicare?

What is the trend of Themis Medicare share price?